Form 8-K - Current report:
SEC Accession No. 0001641172-25-010525
Filing Date
2025-05-15
Accepted
2025-05-15 08:05:13
Documents
15
Period of Report
2025-05-15
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 37790
2 EX-99.1 ex99-1.htm EX-99.1 65922
3 GRAPHIC ex99-1_001.jpg GRAPHIC 48359
  Complete submission text file 0001641172-25-010525.txt   354553

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pulm-20250515.xsd EX-101.SCH 3018
5 XBRL LABEL FILE pulm-20250515_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE pulm-20250515_pre.xml EX-101.PRE 22361
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3685
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 25948827
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)